# Parkinson's Disease Inflammatory Biomarker Profiling

> **NCT03633513** · — · TERMINATED · sponsor: **Longevity Biotech** · enrollment: 99 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIAGNOSTIC_TEST:** LBT-3627
- **DIAGNOSTIC_TEST:** Immunological profiling

## Key facts

- **NCT ID:** NCT03633513
- **Lead sponsor:** Longevity Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-10
- **Primary completion:** 2020-03-13
- **Final completion:** 2020-03-13
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** COVID-19
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03633513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03633513, "Parkinson's Disease Inflammatory Biomarker Profiling". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03633513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*